Berkshire Hathaway Inc stock faces valuation scrutiny amid leadership transition and cash pile challenges

Berkshire Hathaway Inc (ISIN: US0846701086) Class B shares traded softer on NYSE in USD, prompting fresh debates on whether the conglomerate remains undervalued at current levels. Investors watch Greg Abel's impending solo leadership and the $373 billion cash deployment strategy. DACH investors eye steady returns in uncertain times. (As of March 20, 2026)

Berkshire Hathaway Inc Class B shares (NYSE: BRK.B, USD) closed at $492.01 on March 18, 2026, reflecting a 1.66% decline from the prior session amid broader market caution. The stock has softened 1.62% over the past month, yet year-to-date gains stand at 8.54%. This pullback revives questions on valuation as Warren Buffett nears the end of his CEO tenure, with Greg Abel set to lead solo. For DACH investors, Berkshire's fortress balance sheet offers a rare US conglomerate play with European-like stability, immune to many tech froths.

As of: 20.03.2026

By Eleanor Voss, Senior Financial Analyst specializing in US conglomerates and value investing strategies. With Berkshire Hathaway Inc navigating post-Buffett era, focus sharpens on capital allocation amid record cash reserves.

Recent Share Performance and Market Context

Berkshire Hathaway Inc Class A shares (NYSE: BRK.A, USD) traded between $759,691 and $773,247 on recent sessions, closing around $763,530 with a market cap exceeding $1.1 trillion. Class B shares, more accessible to retail investors, mirrored this with NYSE closes near $492 in USD. The 52-week range for BRK.A spans $660,640 to $812,855 in USD, underscoring resilience despite volatility.

Over five years, BRK.B has surged 136%, outpacing many peers. Yet recent momentum softened: a 2.63% drop in 30 days and 7.77% one-year total return lag. This comes as US markets grapple with interest rate expectations and election cycles, but Berkshire's diversified holdings buffer sector risks.

For DACH investors, this stability appeals. German-speaking markets favor predictable earners like Berkshire, akin to Allianz or Siemens in diversification, but with Buffett's value discipline honed over decades.

Valuation Debate: Undervalued or Fairly Priced?

Analysts peg BRK.B fair value at $532 per share using a 1.6x price-to-book multiple on projected 2025 book value of $332.55, implying 8.9% undervaluation from recent $484-492 NYSE USD levels. This premium over historical 1.5x reflects $373 billion cash pile generating massive interest income, plus gains in energy and railroad margins.

The model acts as a 'valuation magnet,' drawing shares toward $530+ as insurance cycles improve in late 2026. Berkshire avoids tech growth multiples, relying on capital allocation prowess. P/E sits at 16.28, reasonable for a $1 trillion+ entity with no dividend yet strong buybacks.

DACH investors, accustomed to conservative valuations in DAX firms, find this compelling. Berkshire's book value growth historically compounds at double-digits, mirroring Swissblue-chip reliability.

Leadership Transition: Abel's Solo Era Begins

Warren Buffett's CEO exit looms by late 2026, thrusting Greg Abel into full command. Investors assess if Abel can replicate Buffett's magic in deploying the cash hoard. Recent softer trading ties to this uncertainty, yet Abel's track record in energy (Berkshire Hathaway Energy) inspires confidence.

Berkshire's structure as a holding company shines here: subsidiaries like GEICO, BNSF Railway run autonomously. This decentralization eases transition risks, unlike centralized tech giants. Cash interest income alone rivals many firms' profits, buying time for deals.

Why now? Markets price in post-Buffett discounts prematurely. DACH investors value such succession planning, recalling smooth handovers at Nestle or Roche.

Cash Pile Dynamics and Deployment Options

At $373.3 billion, Berkshire's cash rivals small nations' GDPs, yielding hefty interest in high-rate environments. Yet reinvestment challenges mount as quality assets scarcer post-Apple stake sales. Options include buybacks (aggressive at current multiples), acquisitions, or insurance float leverage.

Energy and railroad segments boost margins, offsetting insurance pressures. Catastrophe losses could derail, but diversified underwriting mitigates. This cash fortress shields from recessions, a key draw for risk-averse DACH portfolios.

European investors note parallels to Volkswagen's cash wars or BASF's allocation debates, but Berkshire's discipline stands out.

Segment Highlights: Insurance, Rail, Energy

Insurance underwriting remains core, with float funding investments. Recent cycles test pricing power, but improved margins expected. BNSF Railway benefits from US infrastructure spend, while Berkshire Hathaway Energy grows renewables amid global transitions.

Consumer brands like Dairy Queen, Fruit of the Loom add stability. No dividend policy preserves capital, contrasting yield-chasing Europeans but rewarding compounding.

DACH relevance: Berkshire's industrial exposures align with German Mittelstand strengths, offering transatlantic diversification.

Risks and Open Questions for Investors

Key risks include persistent insurance losses from catastrophes, cash reinvestment flops, or regulatory scrutiny on size. Succession beyond Abel poses longer-term queries. Macro headwinds like rate cuts could trim interest income.

Valuation risks if multiples compress post-Buffett. Yet historical resilience—surviving 2008, COVID—bolsters case. Volatility suits patient holders, not traders.

Why DACH Investors Should Watch Closely

For German, Austrian, Swiss investors, Berkshire Hathaway Inc provides unmatched US exposure: diversified, cash-rich, value-oriented. Amid Eurozone uncertainties, its USD assets hedge currency risks. ETFs limit access, but direct BRK.B holds appeal for larger portfolios.

Post-Buffett proof will affirm or challenge lore. Current softness offers entry for long-termists seeking 10%+ annual compounds. Track quarterly reports for cash moves, Abel updates.

Relevance peaks now: leadership shift coincides with favorable insurance outlook, positioning for rebound toward $530 NYSE USD targets.

Disclaimer: This is not investment advice. Stocks are volatile financial instruments.